{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:28:55Z","timestamp":1790803735271,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016032","name":"Nederlandse Cystic Fibrosis Stichting","doi-asserted-by":"publisher","award":["R6266"],"award-info":[{"award-number":["R6266"]}],"id":[{"id":"10.13039\/100016032","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["chestpulmonary.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST Pulmonary"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.chpulm.2025.100146","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T19:16:47Z","timestamp":1738955807000},"page":"100146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mental Health Changes in Adolescents and Adults With Cystic Fibrosis After Initiation of Elexacaftor\/Tezacaftor\/Ivacaftor Therapy"],"prefix":"10.1016","volume":"3","author":[{"given":"Els","family":"van der Heijden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutger M.","family":"van den Bor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlou C.","family":"Bierlaagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3091-2831","authenticated-orcid":false,"given":"Danya","family":"Muilwijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7357-6164","authenticated-orcid":false,"given":"Jessica M.","family":"de Graaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1538-5014","authenticated-orcid":false,"given":"Sanne L.","family":"Nijhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inez","family":"Bronsveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis K.","family":"van der Ent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4632-7821","authenticated-orcid":false,"given":"Sabine E.I.","family":"van der Laan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"S1","key":"10.1016\/j.chpulm.2025.100146_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/ppul.25733","article-title":"Increasing life expectancy in cystic fibrosis: advances and challenges","volume":"57","author":"McBennett","year":"2022","journal-title":"Pediatr Pulmonol"},{"issue":"9","key":"10.1016\/j.chpulm.2025.100146_bib2","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1007\/s00431-021-04168-y","article-title":"A new era for people with cystic fibrosis","volume":"180","author":"Bierlaagh","year":"2021","journal-title":"Eur J Pediatr"},{"issue":"12","key":"10.1016\/j.chpulm.2025.100146_bib3","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1002\/ppul.25627","article-title":"Review of CFTR modulators 2020","volume":"56","author":"Goetz","year":"2021","journal-title":"Pediatr Pulmonol"},{"issue":"19","key":"10.1016\/j.chpulm.2025.100146_bib4","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor\u2013tezacaftor\u2013ivacaftor for cystic fibrosis with a single Phe508del allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Engl J Med"},{"issue":"10212","key":"10.1016\/j.chpulm.2025.100146_bib5","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.chpulm.2025.100146_bib6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jcf.2022.08.018","article-title":"Non-respiratory health-related quality of life in people with cystic fibrosis receiving elexacaftor\/tezacaftor\/ivacaftor","volume":"22","author":"Fajac","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.chpulm.2025.100146_bib7","first-page":"554","article-title":"Efficacy and safety of elexacaftor-tezacaftor-ivacaftor in the treatment of cystic fibrosis: a systematic review","volume":"10","author":"Kapouni","year":"2023","journal-title":"Children (Basel)"},{"key":"10.1016\/j.chpulm.2025.100146_bib8","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jcf.2022.05.001","article-title":"Dose adjustments of elexacaftor\/tezacaftor\/ivacaftor in response to mental health side effects in adults with cystic fibrosis","volume":"21","author":"Spoletini","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.chpulm.2025.100146_bib9","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jcf.2021.10.002","article-title":"Mental status changes during elexacaftor\/tezacaftor\/ivacaftor therapy","volume":"21","author":"Heo","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.chpulm.2025.100146_bib10","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.psym.2020.06.021","article-title":"Trikafta and psychopathology in cystic fibrosis: a case report","volume":"61","author":"Tindell","year":"2020","journal-title":"Psychosomatics"},{"issue":"3","key":"10.1016\/j.chpulm.2025.100146_bib11","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1164\/rccm.202308-1525OC","article-title":"Elexacaftor\/tezacaftor\/ivacaftor treatment and depression-related events","volume":"209","author":"Ramsey","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chpulm.2025.100146_bib12","doi-asserted-by":"crossref","DOI":"10.1177\/17534666221144211","article-title":"Impact of elexacaftor\/tezacaftor\/ivacaftor on depression and anxiety in cystic fibrosis","volume":"16","author":"Zhang","year":"2022","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.chpulm.2025.100146_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1179208","article-title":"Effects of elexacaftor\/tezacaftor\/ivacaftor therapy on mental health of patients with cystic fibrosis","volume":"14","author":"Piehler","year":"2023","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.chpulm.2025.100146_bib14","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.chest.2023.10.043","article-title":"Longitudinal effects of elexacaftor\/tezacaftor\/ivacaftor: Multidimensional Assessment of Neuropsychological Side Effects and Physical and Mental Health Outcomes in Adolescents and Adults","volume":"165","author":"Graziano","year":"2024","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.chpulm.2025.100146_bib15","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/ppul.26412","article-title":"Management of neuropsychiatric symptoms in adults treated with elexacaftor\/tezacaftor\/ivacaftor","volume":"58","author":"Baroud","year":"2023","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"10.1016\/j.chpulm.2025.100146_bib16","doi-asserted-by":"crossref","first-page":"00535","DOI":"10.1183\/23120541.00535-2022","article-title":"The RISE study protocol: resilience impacted by positive stressful events for people with cystic fibrosis","volume":"9","author":"van der Heijden","year":"2023","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.chpulm.2025.100146_bib17","author":"Varni"},{"key":"10.1016\/j.chpulm.2025.100146_bib18","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/00005650-199902000-00003","article-title":"The PedsQLTM measurement model for the pediatric quality of life inventory","volume":"3","author":"Varni","year":"1999","journal-title":"Med Care"},{"issue":"10","key":"10.1016\/j.chpulm.2025.100146_bib19","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"issue":"9","key":"10.1016\/j.chpulm.2025.100146_bib20","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"issue":"4","key":"10.1016\/j.chpulm.2025.100146_bib21","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1378\/chest.128.4.2347","article-title":"Development and validation of the cystic fibrosis questionnaire in the United States","volume":"128","author":"Quittner","year":"2005","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.chpulm.2025.100146_bib22","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1177\/1359105309103580","article-title":"The PedsQLTM 4.0 Generic Core Scales Young Adult Version","volume":"14","author":"Varni","year":"2009","journal-title":"J Health Psychol"},{"issue":"4","key":"10.1016\/j.chpulm.2025.100146_bib23","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.pcl.2009.05.016","article-title":"The Pediatric Quality of Life Inventory: measuring pediatric health-related quality of life from the perspective of children and their parents","volume":"56","author":"Varni","year":"2009","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.chpulm.2025.100146_bib24","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jad.2020.01.032","article-title":"Sensitivity to change and minimal clinically important difference of the 7-item Generalized Anxiety Disorder Questionnaire (GAD-7)","volume":"265","author":"Toussaint","year":"2020","journal-title":"J Affect Disord"},{"issue":"6","key":"10.1016\/j.chpulm.2025.100146_bib25","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/PSY.0000000000000322","article-title":"Patient Health Questionnaire Anxiety and Depression Scale: initial validation in three clinical trials","volume":"78","author":"Kroenke","year":"2016","journal-title":"Psychosom Med"},{"issue":"12","key":"10.1016\/j.chpulm.2025.100146_bib26","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1097\/00005650-200412000-00006","article-title":"Monitoring depression treatment outcomes with the Patient Health Questionnaire-9","volume":"42","author":"Lowe","year":"2004","journal-title":"Med Care"},{"issue":"6","key":"10.1016\/j.chpulm.2025.100146_bib27","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jcf.2023.06.009","article-title":"Longitudinal mental health trends in cystic fibrosis","volume":"22","author":"Hjelm","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.chpulm.2025.100146_bib28","article-title":"Impact of elexacaftor\/tezacaftor\/ivacaftor on lung function, nutritional status, pulmonary exacerbation frequency and sweat chloride in people with cystic fibrosis: real-world evidence from the German CF Registry","volume":"32","author":"Sutharsan","year":"2023","journal-title":"Lancet Reg Health Eur"},{"issue":"3","key":"10.1016\/j.chpulm.2025.100146_bib29","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S2352-4642(18)30022-1","article-title":"The age of adolescence","volume":"2","author":"Sawyer","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"issue":"3","key":"10.1016\/j.chpulm.2025.100146_bib30","first-page":"1","article-title":"MICE: multivariate imputation by chained equations in R","volume":"45","author":"van Buuren","year":"2011","journal-title":"J Stat Softw"},{"issue":"5","key":"10.1016\/j.chpulm.2025.100146_bib31","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1037\/met0000556","article-title":"Pooling methods for likelihood ratio tests in multiply imputed data sets","volume":"28","author":"Grund","year":"2023","journal-title":"Psychol Methods"},{"key":"10.1016\/j.chpulm.2025.100146_bib32","author":"Robitzsch"},{"key":"10.1016\/j.chpulm.2025.100146_bib33","author":"Pinheiro"},{"key":"10.1016\/j.chpulm.2025.100146_bib34","author":"Lenth"},{"issue":"1","key":"10.1016\/j.chpulm.2025.100146_bib35","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/alr.22700","article-title":"Effect of highly effective modulator therapy on quality of life in adults with cystic fibrosis","volume":"11","author":"DiMango","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"issue":"12","key":"10.1016\/j.chpulm.2025.100146_bib36","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1136\/thoraxjnl-2014-205983","article-title":"Prevalence of depression and anxiety in patients with cystic fibrosis and parent caregivers: results of The International Depression Epidemiological Study across nine countries","volume":"69","author":"Quittner","year":"2014","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.chpulm.2025.100146_bib38","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.psym.2017.04.001","article-title":"Cystic fibrosis transmembrane regulator modulators: implications for the management of depression and anxiety in cystic fibrosis","volume":"58","author":"Talwalkar","year":"2017","journal-title":"Psychosomatics"}],"container-title":["CHEST Pulmonary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949789225000133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949789225000133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T12:58:15Z","timestamp":1778936295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949789225000133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2949789225000133"],"URL":"https:\/\/doi.org\/10.1016\/j.chpulm.2025.100146","relation":{},"ISSN":["2949-7892"],"issn-type":[{"value":"2949-7892","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mental Health Changes in Adolescents and Adults With Cystic Fibrosis After Initiation of Elexacaftor\/Tezacaftor\/Ivacaftor Therapy","name":"articletitle","label":"Article Title"},{"value":"CHEST Pulmonary","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chpulm.2025.100146","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc under license from the American College of Chest Physicians.","name":"copyright","label":"Copyright"}],"article-number":"100146"}}